Omadacycline in Vitro Activity Against a Molecularly Characterized Collection of Clinical Isolates with Known Tetracycline Resistance Mechanisms

被引：0
|
作者：
不详
机构：
来源：
AMERICAN HEALTH AND DRUG BENEFITS | 2018年 / 11卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：489 / 489
页数：1
相关论文
共 50 条
  • [11] Omadacycline Efficacy against Enterococcus faecalis Isolated in China: In Vitro Activity, Heteroresistance, and Resistance Mechanisms
    Lin, Zhiwei
    Pu, Zhangya
    Xu, Guangjian
    Bai, Bing
    Chen, Zhong
    Sun, Xiang
    Zheng, Jinxin
    Li, Peiyu
    Qu, Di
    Deng, Qiwen
    Yu, Zhijian
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (03)
  • [12] Comparative in vitro activity of PGE 9262932 and fluoroquinolones against Canadian clinical Streptococcus pneumoniae isolates, including molecularly characterized ciprofloxacin-resistant isolates
    Adam, Heather J.
    Schurek, Kristen N.
    DeCorby, Melanie R.
    Weshnoweski, Barbara
    Vashisht, Ravinder
    Karlowsky, Kathy
    Hoban, Daryl J.
    Zhanel, George G.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (01) : 202 - 204
  • [13] In vitro activity of omadacycline against geographically diverse rapidly growing nontuberculous mycobacteria (NTM) clinical isolates
    Terschlusen, Eva
    Aono, Akio
    Anastasiou, Diane M.
    Serio, Alisa W.
    Mitarai, Satoshi
    van Ingen, Jakko
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2025, 111 (03)
  • [14] TIGEMONAM ACTIVITY AGAINST CLINICAL ISOLATES OF ENTEROBACTERIACEAE AND ENTEROBACTERIACEAE WITH KNOWN MECHANISMS OF RESISTANCE TO BETA-LACTAM ANTIBIOTICS
    NELET, F
    GUTMANN, L
    KITZIS, MD
    ACAR, JF
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 24 (02) : 173 - 181
  • [15] In Vitro Activity of Garenoxacin against Streptococcus pneumoniae Mutants with Characterized Resistance Mechanisms
    Yamamoto, Kazuko
    Yanagihara, Katsunori
    Sugahara, Kazuyuki
    Imamura, Yoshifumi
    Seki, Masafumi
    Izumikawa, Koichi
    Kakeya, Hiroshi
    Yamamoto, Yoshihiro
    Hirakata, Yoichi
    Kamihira, Shimeru
    Kohno, Shigeru
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (08) : 3572 - 3575
  • [16] Comparative In Vitro Activity of Omadacycline against Dog and Cat Bite Wound Isolates
    Goldstein, Ellie J. C.
    Citron, Diane M.
    Tyrrell, Kerin L.
    Leoncio, Eliza
    Merriam, C. Vreni
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (04)
  • [17] In vitro activity of tetracycline analogs against multidrug-resistant and extensive drug resistance clinical isolates of Mycobacterium tuberculosis
    Zhang, Chi
    Ouyang, Qi
    Zhou, Xianyuan
    Huang, Yingfeng
    Zeng, Yu
    Deng, Li
    Lin, Dachuan
    Zheng, Weidong
    TUBERCULOSIS, 2023, 140
  • [18] Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms
    Sanglard, Dominique
    Coste, Alix T.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (01) : 229 - 238
  • [19] COMPARATIVE IN-VITRO ACTIVITY OF BIAPENEM AND OTHER CARBAPENEMS AGAINST HAEMOPHILUS-INFLUENZAE ISOLATES WITH KNOWN RESISTANCE MECHANISMS TO AMPICILLIN
    YEO, SF
    LIVERMORE, DM
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (04) : 861 - 865
  • [20] In Vitro Activity of KBP-7072, a Novel Third-Generation Tetracycline, against 531 Recent Geographically Diverse and Molecularly Characterized Acinetobacter baumannii Species Complex Isolates
    Huband, Michael D.
    Mendes, Rodrigo E.
    Pfaller, Michael A.
    Lindley, Jill M.
    Strand, Gregory J.
    Benn, Vincent J.
    Zhang, Jay
    Li, Li
    Zhang, Min
    Tan, Xiaojuan
    Liu, Qingmei
    Flamm, Robert K.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (05)
12345